Coston, Mc Isaac & Partners Novartis Ag Transaction History
Coston, Mc Isaac & Partners
- $293 Million
- Q2 2025
A detailed history of Coston, Mc Isaac & Partners transactions in Novartis Ag stock. As of the latest transaction made, Coston, Mc Isaac & Partners holds 170 shares of NVS stock, worth $21,953. This represents 0.01% of its overall portfolio holdings.
Number of Shares
170
Previous 170
-0.0%
Holding current value
$21,953
Previous $18,000
11.11%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,576Shares Held
136MCall Options Held
1.72MPut Options Held
1.7M-
Dodge & Cox San Francisco, CA10.6MShares$1.38 Billion0.78% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.34 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX9.06MShares$1.17 Billion0.26% of portfolio
-
Morgan Stanley New York, NY7.56MShares$976 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa7.12MShares$920 Million0.35% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $278B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...